Proteomic Associations of Adverse Outcomes in Human Heart Failure

Background Identifying novel molecular drivers of disease progression in heart failure (HF) is a high‐priority goal that may provide new therapeutic targets to improve patient outcomes. The authors investigated the relationship between plasma proteins and adverse outcomes in HF and their putative ca...

詳細記述

書誌詳細

主要な著者:	Marie‐Joe Dib, Michael G. Levin, Lei Zhao, Ahmed Diab, Zhaoqing Wang, Christina Ebert, Oday Salman, Joe David Azzo, Sushrima Gan, Payman Zamani, Jordana B. Cohen, Dipender Gill, Stephen Burgess, Loukas Zagkos, Vanessa van Empel, A. Mark Richards, Rob Doughty, Ernst R. Rietzschel, Karl Kammerhoff, Erika Kvikstad, Joseph Maranville, Peter Schafer, Dietmar A. Seiffert, Francisco Ramirez‐Valle, David A. Gordon, Ching‐Pin Chang, Ali Javaheri, Douglas L. Mann, Thomas P. Cappola, Julio A. Chirinos
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2024-03-01
シリーズ:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主題:	heart failure HFrEF Mendelian randomization proteomics
オンライン･アクセス:	https://www.ahajournals.org/doi/10.1161/JAHA.123.031154
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!